SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-146223
Filing Date
2020-05-19
Accepted
2020-05-19 17:02:42
Documents
12
Period of Report
2020-05-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d902360d8k.htm   iXBRL 8-K 39824
  Complete submission text file 0001193125-20-146223.txt   159914

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA sgen-20200515.xsd EX-101.SCH 3091
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgen-20200515_lab.xml EX-101.LAB 17374
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgen-20200515_pre.xml EX-101.PRE 10967
6 EXTRACTED XBRL INSTANCE DOCUMENT d902360d8k_htm.xml XML 3271
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
SEATTLE GENETICS INC /WA (Filer) CIK: 0001060736 (see all company filings)

IRS No.: 911874389 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-32405 | Film No.: 20894552
SIC: 2836 Biological Products, (No Diagnostic Substances)